News

Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...
Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...
Remegen's Telitacicept met its primary endpoints in a Chinese trial, while a US-based Phase III trial in Sjögren's syndrome ...
The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.
India had refused accept demands from the UK and Switzerland for data exclusivity to protect generic pharma industry, with ...
Drugs to treat attention deficit hyperactivity disorder were linked to a reduced risk of suicidal behavior, substance misuse and criminality in the first research of its kind.
Medulla Communications Pvt. Ltd., one of the world's most awarded healthcare-specialist advertising agencies, has announced the launch of its new hub in Singapore. With over 15 years of experience in ...
Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...
HAVAS Africa has launched HAVAS Red Nigeria, marking a step in the global merged media agency’s growth across West Africa and ...
The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...
President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.
While Vor provided no details on the results, the company is now evaluating a global trial of the drug in the chronic immune ...